Abstract. The process of tumorigenesis induces alterations in numerous cellular pathways including the main eukaryotic metabolic routes. It has been recently demonstrated that autophagy is part of the oncogene-induced senescence phenotype although its role in tumor establishment has not been completely clarified. In the present study, we showed that non-transformed cells are sensitized to mitochondrial stress and autophagy induction when they are transformed by oncogenes such as c-Myc or Ras. We observed that overexpression of c-Myc or Ras increased AMP-activated protein kinase (AMPK) phosphorylation and the expression of p62, a known partner for degradation by autophagy. The activation of AMPK was found to favor the activation of FoxO3 which was prevented by the inhibition of AMPK. The transcriptional activation mediated by FoxO3 upregulated genes such as BNIP3 and LC3. Finally, the transformation by oncogenes such as c-Myc and Ras predisposes tumor cells to autophagy induction as a consequence of mitochondrial stress and impairs tumor growth in vitro and in vivo, which may have therapeutic implications.
Introduction
Macroautophagy, also known as autophagy, is a catabolic process that operates by generating several benefits for the cell, protecting it against multiple stress stimuli. In the majority of cases, autophagy functions as a recycling and recovery system for proteins, lipids and DNA damage; therefore, the cell eliminates various compounds that may be toxic, and also generates ATP. It has been reported that autophagy protects the cell against DNA damage, chromosomal instability and metabolic stress (1) . The exogenous expression of a great variety of oncogenes leads to tumorigenesis which is often accompanied by metabolic changes. In this aspect, one of the better examples is aneuploid tumors, where the additional chromosomes bear an increased amount of various proteins, affecting protein folding and turnover. The overaccumulation of proteins induces the activation of adaptive processes to alleviate this proteotoxic effect, such as the increase in chaperone Hsp72, the activation of AMPK or the degradation mediated by autophagy (1) . These alterations of the metabolism in this type of tumor offer the possibility of blocking autophagy or generating metabolic stress as a therapeutic strategy due to the differential sensitivity of cancer cells (2) .
Numerous oncogenic processes favor adaptations of signaling pathways to allow tumor transformation, although they generate cellular stress. This affects the autophagic pathway since in the majority of stress conditions the cells activate several signaling pathways, such as mTOR, AMPK, p53, JNK, FoxO3 among others, which regulate, positively or negatively, the induction of autophagic vacuoles. Most of these pathways control the expression of proteins related to vacuole generation, such as the Atgs. In contrast, both p53 and FoxO3 have been found to induce genes such as Sestrin 2 and DRAM or BNIP3 and GABARAP, respectively. However, various functions of these genes have not been completely elucidated since they are only associated with an increased degradative phase and in some circumstances with cell death.
During the Ras-mediated process of oncogenesis, there is an induction of autophagy through negative feedback in which Ras-Raf activation shrinks the PI3K pathway, reducing AKT phosphorylation (3). Therefore, this decrease in Akt activity reduces FoxO repression and permits the upregulation of protein, such as LC3, BNIP3 and ULK (4) . In this manner, RAS-v12 overexpression induces an increase in autophagy that is associated with oncogene-induced senescence (OIS) hallmarks and also with the formation of TOR-autophagy spatial coupling compartment (TASCC) that mediates the secretion of interleukin-6/8, which are involved in senescence (5, 6) . If once transformation is established and the stress situation is maintained, this generates autophagy dependence or an increase in the glucose uptake as previously demonstrated (7, 8) .
In contrast, the involvement of AMPK in the regulation of metabolism and autophagy has been widely demonstrated. This kinase performs several functions that link metabolism and proliferation. In addition to its function as a sensor of the ATP/AMP ratio, this kinase is activated in response to oxidative and proteolytic stress. In this sense, it has been recently reported that AMPK directly phosphorylates FoxO3 in its Ser413 and Ser588 residues, increasing the transcription of various FoxO3 regulated genes, such as Gadd45α (9) . Thus, much of the metabolic adaptation in cells which undergo oncogenic transformation may induce a differential response of AMPK depending on ATP levels, oxidative stress and autophagy.
Oncogene-mediated tumor transformation sensitizes cells to autophagy induction
In the present study, we demonstrated that the overexpression of c-Myc or RAS-v12 in untransformed mammary cells activates AMPK and that the phosphorylation of FoxO3 increases the transcription of genes such as BNIP3. Using a powerful system of mitophagy induction, the linamarase/ linamarin/glucose oxidase system (lis/lin/GO) (10, 11) , we demonstrated that c-Myc or RAS-v12 transformation sensitized cells to autophagy, in vitro and in vivo.
Materials and methods
Reagents and antibodies. The antibody against FoxO3 P-ser413 was a kind gift from Dr Anne Brunet (Department of Genetics, Stanford University, Stanford, CA, USA). The commercial primary antibodies used were: FoxO3 and phospho-AMPKα (Thr172) (Cell Signaling, Danvers, MA, USA); pan-RAS (Calbiochem, Darmstadt, Germany); p62 (BD Biosciences, Bedford, CA, USA); E-cadherin and c-Myc (sc-788) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); LC-3, BNiP3 and actin (Sigma, St. Louis, MO, USA). The secondary antibodies for western blot analysis were horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgGs (Santa Cruz Biot`echnology). The reagents used were: linamarin (lin; 500 µg/ml; Toronto Research Chemicals, Toronto, Canada), glucose oxidase (GO; 5-5.5 mEU/ml), 3-methyladenine (3MA; 10 mM) and thiazolyl blue tetrazolium bromide (MTT; 200 µg/ml) (all from Sigma), bafilomycin A1 and compound C (10 µM) (from Calbiochem).
Media and cell culture. The MCF7 cell line was cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Life Technologies, Barcelona, Spain) supplemented with 10% fetal calf serum (FCS) at 37˚C in 7% CO 2 and 97% relative humidity. The MCF10A cell line was grown as recommended by Joan S. Brugge (Whitehead Institute for Biomedical Research, Cambridge, MA, USA) in DMEM:F12 media (1:1) supplemented with 10 µg/ml insulin (Gibco), 20 ng/ml EGF (Tocris, Bristol, UK), 0.5 µg/ml hydrocortisone (Calbiochem), 100 ng/ml cholera toxin and 5% horse serum at 37˚C in 7% CO 2 and 97% relative humidity.
Adenovirus, lentivirus and retrovirus production. Adenolis vectors were obtained from Crucell (Leiden, The Netherlands). Pseudotyped lentivectors were produced using reagents and protocols from Didier Trono with the following modifications: 293T cells were transiently co-transfected with 5 µg of the corresponding lentivector plasmid, 5 µg of the packaging plasmid pCMVdR8.74 and 2 µg of the VSV-G envelope protein plasmid pMD2G using Lipofectamine Plus reagent following instructions of the supplier (Invitrogen, Life Technologies, Barcelona, Spain). The lentivectors included pMIG-h-c-Myc, that was kindly provided by Maria Soengas (CNIO, Madrid, Spain) (12) , and pLenti-RAS-v12 provided by Judith Campisi (Lawrence Berkeley National Laboratory, Berkeley, CA, USA) (13) which encode human c-Myc and constitutively active RAS, respectively. To generate the different MCF10A derivative cells, the retroviral vectors used were pBabe, pBabe-dnFoxO3 and pBabe-FoxO3A (caFoxO3) that were kindly provided by Dr Clemens Schmitt (Max Delbrück Center for Molecular Medicine, Berlin, Germany). The retrovirus supernatant was prepared by transfection of phoenix-Ampho cells (Garry Nolan; http://www.stanford.edu/group/nolan/) with 5 µg of each plasmid with Lipofectamine Plus as previously mentioned, and infected cells were selected with 0.5 µg/ ml of puromycin.
Soft agar assay. To evaluate the tumorigenic potential, 2x10 4 viable cells/well were plated in soft agar in 6-well plates. Briefly, the base layer was constructed by mixing equal agar and 2X medium, to obtain a final solution of 0.5% agar in 1X DMEM:F12 medium and for the top layer, the agar was diluted to 0.7% in distilled water with 2X DMEM medium. The cells were immediately added to the mix to yield a final solution of 0.35% agar in 1X DMEM medium, containing 30,000 cells/ml. The cells were grown for 10 days at 37˚C in a humidified atmosphere containing 5% CO 2 , and viable colonies were then stained with 1 ml/well of 600 µg/ml MTT for 2 h and then were photographed.
Immunoblot analysis. Cell lysates were prepared by extracting proteins with lysis buffer (50 mM pH 7.5 Tris-HCl, 300 mM NaCl, 0.5% SDS and 1% Triton X-100). Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA). The blots were developed using peroxidase-conjugated secondary antibody, and proteins were visualized using an enhanced chemiluminescence-based detection kit (Pierce, Rockford, IL, USA).
Mice and treatments. Nude mice, BALB/c nu/nu, were inoculated subcutaneously in both flanks with 1x10 6 MCF7-Ras-lis cells (n=6/group). After 5 days, the animals were intratumorally treated daily with lin (5 mg) and GO (2 EU) in the right tumor while the left one was left untreated. All treatments were performed under general anesthesia with isofluorane (AP/DRUGS/220/96; Baxter, Valencia, Spain). Tumor size (length, width and height) was measured when indicated with a caliper, and the tumor volume (V) was calculated as: V = [π/6(length x width x height)]. For animal care and handling we followed the Spanish legislation and guidelines Statistical analysis. Statistical comparison of the data groups was carried out using the Student's t-test. The differences are expressed with their corresponding statistical significance or p-value, which is the probability that the observation in a sample occurred merely by chance under the null hypothesis.
Results
The purpose of the present study was to verify whether oncogene-mediated transformation sensitizes cells to autophagy. For this purpose we used two alternative approaches, the transfection of c-Myc (14,15) or a mutant version of ras (RASv12) (16), and we initially used MCF10A, an untransformed mammary cell line, as a cell model. Next, we transfected and generated cell lines expressing either c-Myc or RASv12 (HrasVal12) or an empty vector containing GFP as an internal control. The c-Myc-and RASv12-expressing cells were characterized at three levels. First they were phenotypically altered giving the appearance of a mesenchymal-like phenotype (Fig. 1A) . Second, both oncogenic transformations conferred MCF10A cells the ability of anchorage-independent growth forming colonies in soft agar when compared with the mock-transfected cells (LV-GFP) (Fig. 1B) . Third, they expressed and maintained a high level of either c-Myc or RAS as confirmed by western blotting (Fig. 1C) .
As an initial indicator of autophagic vesicles, we determined the level of LC3-II. We showed that c-Myc-transformed cells, while more prominent in Ras-transformed cells, showed an increase in the amount of total LC3B, as well as an increase in the LC3-II form. Next, we inferred the activity of AMPK by determining the phosphorylation levels of Thr172-AMPK. Notably, both oncogenes were capable of increasing phosphorylation of this residue (Fig. 1C) . This kinase activation permitted us to conclude that the amount of ATP/AMP and NADP/ NADPH were modified in response to the 'oncogenic stress'.
The increase in LC3-II indicated differences in autophagy dynamics. Thus, we next analyzed how the RASv12-transformed cells respond to a drug that induces mitochondrial stress, when compared with the parental cell lines. For this purpose, we used the MCF10A-GFP and MCF10A-RASv12 cells, as well as a breast tumor cell line (MCF7), transfected with both constructs (GFP and RASv12).
The cell lines containing GFP or RASv12, derived from either MCF10A or MCF7 cells, were treated with lis/lin/GO, that produced mitochondrial stress and consequently induced potent autophagy as previously described (10, 11) . The lis/lin/GO treatment showed a marked growth inhibition in the MCF10A cells either untransformed (LV-GFP) ( Fig. 2A) or transformed (LV-RASv12) (Fig. 2C) as determined by the MTT assay. Similar results were observed in the MCF7 and MCF7-RASv12 cells (Fig. 2B and D) .
Notably, when we used a wide inhibitor of class III PI3K, 3-methyladenine (3MA), this effect was prevented or highly diminished only in the RAS-transformed cells in both cell types ( Fig. 2C and D) , whereas in the non-transformed cells the toxic effect generated by the lis/lin/GO system was not prevented ( Fig. 2A and B) .
Collectively, we conclude that the RAS-expressing cells were more sensitive to the inhibition of autophagy. To confirm this hypothesis, we determined whether the levels of p62, one of the main partners of LC3B (17, 18) , is modified by the lis/ lin/GO treatment. Thus, we observed that either c-Myc or RAS transformation increased the amount of p62, and this protein level was reduced, probably by degradation, when autophagy was triggered by lis/lin/GO treatment in either the c-Myc-or Ras-expressing MCF10A cells (Fig. 3A) .
There is a close relationship between metabolism and cellular damage generated by stress. In addition the mitochondrial toxic effect generated by the lis/lin/GO system permitted us to hypothesize the participation of AMPK in AMP/ATP deregulation. We showed that Myc or RAS transformation generated an increase in AMPK activity (Fig. 1C) , and inhibition of AMPK by compound C (10 µM) partially recovered the cell survival reduced by lis/lin/GO treatment in the MCF10A-RASv12 cells (Fig. 3B) .
It has been previously reported that AMPK mediates FoxO3-positive regulation of energy balance and stress (9) . This transcriptional factor controls the expression of an important set of genes related to autophagy, such as LC3B or BNIP3 among others, as reported in RAS-mediated senescence or in muscular atrophy (4, 19, 20) . Therefore, to validate the activation of AMPK due to these tumor transformations, we analyzed the expression of phosphorylated FoxO3 and the protein levels of LC3B and BNIP3. Our data indicated that both c-Myc and RAS activated AMPK by increasing the level of phosphorylated AMPKα in Thr172 (pAMPK) (Fig. 4A) ; in parallel LC3-II was increased (Fig. 4A ). This activation of AMPK was correlated with an increase in p-FoxO3-Ser413, coinciding with an increase in BNIP3 and LC3B (Fig. 4A) . This AMPK kinase activation was confirmed since following incubation with the inhibitor compound C (10 µM) both FoxO3-Ser413 phosphorylation and BNIP3 and LC3B expression were severely reduced (Fig. 4A) . The additional stress generated by the lis/lin/GO system increased p-AMPK-Thr172 as well as FoxO3-Ser413, which were correlated with an increase in BNIP3 expression and LC3-II (Fig. 4B) more markedly in the c-Myc-and RAS-transformed cells. Similarly the addition of AMPK inhibitor, compound C, completely blocked FoxO3 phosphorylation, therefore preventing BNIP3 and LC3-II induction (Fig. 4A) . Similarly to Compound C, the expression of dominant-negative version of AMPK (AMPK-DN) reduced the enhancement of LC3-II triggered by lin+GO (Fig. 4C) .
To assess the involvement of FoxO3 in the regulation of LC3, we infected MCF10A-RASv12 cells with either a dominantnegative (dnFoxO3) or a constitutively active version of FoxO3 (caFoxO3), as well as an empty virus (pBabe) as a control. It was observed that dnFoxO3 blocked the expression of LC3 as well as the amount of LC3-II (Fig. 5A) ; in contrast, the expression of caFoxO3 increased the level of LC3-II (Fig. 5A) . Notably, the dnFoxO3 construct partially recovered the cell survival rate following lis/lin/GO treatment, while the caFoxO3 construct diminished the survival of the MCF10A-RASv12 cells (Fig. 5B) . The subsequent inhibition of class III PI3K by 3MA increased the survival of the control cells (infected by LV-GFP). Notably, the presence of 3MA increased the survival of the caFoxO3 cells even more than that in the control cells (p=0.045 vs. p=0.0001) (Fig. 5B) , whereas no additional increase was observed in the dnFoxO3 3MA-treated cells (p=0.2) (Fig. 5B ). All these data suggest that autophagy induced by lis/lin/GO was mediated at least in part by FoxO3 activity.
Based on the fact that the lis/lin/GO treatment reduced the growth of MCF7-RASv12 cells, we aimed to ascertain whether this affects the growth capacity of the MCF7-RASv12 tumor cells in vivo. To address this issue, we inoculated MCF7-RAS-lis cells into the flank of nude mice and carried out treatment with vehicle or lis/lin/GO compounds as described in Materials and methods. As shown in Fig. 6A , treatment with lis/lin/GO significantly reduced in vivo tumor growth from day 11 onwards. Additionally we analyzed the induction of autophagy (LC3-II levels) in the untreated and treated tumors. Western blot analyses of the samples (n=4) showed that tumor extracts from the lis/lin/GO-treated tumors showed a substan- tial increase in levels of LC3-II when compared with these levels in the solvent-treated tumors (Fig. 6B ).
In conclusion, transformation mediated by both oncogenes enhanced the sensitivity of the transformed cells to autophagy induction when compared with the untransformed cells. This may have therapeutic interest. This increase in sensitivity under a condition of potent mitochondrial stress is mediated, at least in part, by the AMPK-FoxO3 axis as summarized in the scheme in Fig. 6C .
Discussion
It is widely accepted that tumor cells modify autophagy generating a dependency on this process for maintaining survival and overcoming metabolic stress. Thus, tumor cells are sensitive to the blockage of autophagy (14,21) as well as to its stimulation (22) (23) (24) . It has been previously demonstrated that autophagy is necessary for activated Ras-mediated transformation (7) . In the present study, we demonstrated that tumor processes driven by genes such as c-Myc or RAS (RAS-v12) (14,16,25) sensitized cells to autophagy induction by the lis/lin/GO system. This system has been reported to generate mitochondrial stress-triggering autophagy (10, 11) . Mitochondrial targeting is an attractive antitumor strategy due to the close relationship between oncogenic processes and the modification of the mitochondrial metabolic status (26, 27) . Additionally, mitophagy is a mechanism capable of recycling damaged mitochondria, producing ATP (28) and reducing cellular stress. Therefore, a disturbance in this process can affect the proliferation and survival of tumor cells.
The present data confirmed that the lis/lin/GO system increased AMPK activity, as inferred from phosphorylation of FoxO3 and an increase in genes that are fundamental for autophagy induction such as BNIP3 and LC3B. These data confirm previous reports that indicate that AMPK favors the transcriptional activation of FoxO3 by the phosphorylation of its Ser413 or Ser588 residues (9) , and this transcriptional factor controls the induction of BNIP3 and LC3B genes depending on cell type and context (19, 20) .
In addition, our data demonstrated that the oncogenes, c-Myc and RAS, also modified AMPK activity by generating the upregulation of BNIP3 and LC3B. We demonstrated that the lis/lin/GO-induced autophagy activated this pathway, which was more evident in the RAS-transformed cells, and presented the highest levels of BNIP3 and LC3B in a clear correlation with the phosphorylation of FoxO3. Obviously, we cannot ignore the fact that other regulatory elements such as p38 may contribute to the final regulatory loop after transformation (29) . In cases, transformed cells with or without lis/lin/GO treatment, the inhibitor of AMPK or the dominant-negative version of AMPK prevented the increase in LC3-II. Thus, these data allow the conclusion that autophagy is enhanced in c-Myc and RAS oncogenic models. A similar effect of enhanced autophagy was reported in cancer cells transformed by various tyrosine kinases such as EGFR or Abl (30) (31) (32) (33) . In these cases, tumor progression was associated with an enhancement of autophagy, dependent or independent, of tyrosine kinase activity. Thus, it can be proposed that oncogenic transformation which enhances autophagy is an important mechanism for tumor growth and progression.
Thus, we propose that a high percentage of tumors that bear oncogenes may have proliferative or metabolic stress which makes cells more sensitive to autophagy affecting tumor growth in vitro and in vivo. This susceptibility to the induction of autophagy is regulated, at least in certain cases, by the AMPK-FoxO pathway. Additionally, we hypothesize that autophagy overstimulation by mitochondrial stress induction can be considered as a therapeutic strategy against cancer.
